Table 4.
Selected therapeutic antibodies against new targets
Company | Drug name | Target | Key patent |
Ganymed | GT468 | Placental protein PLAC1 | EP2166021 |
Merrimack | MM-111 | Human epidermal growth factor receptor (HER)2 + HER3 | US7332580 |
LPath | Sphingomab | Sphingosine-1-phosphate | US7829674 |